Dan Levitt
Impact in
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune Response and Inflammation
-
- Telomeres, Telomerase, and Senescence
Papers in
-
- Reproductive System and Pregnancy 2
- Immune Cell Function and Interaction 2
-
- Angiogenesis and VEGF in Cancer 3
- Co-authors
- Feng Wu (1 shared paper)C. K. Osborne (1 shared paper)Naomy Kim (1 shared paper)Gary M. Clark (1 shared paper)Shelly McNeil (1 shared paper)Scott A. Halperin (1 shared paper)Joseph Eiden (1 shared paper)Daniel Gennevois (1 shared paper)
- Journals
- Journal of Allergy and Clinical Immunology (3 papers)Journal of Immunotherapy (2 papers)The Journal of Immunology (2 papers)European Journal of Cancer (2 papers)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- United StatesNetherlandsSwitzerland
In The Last Decade
Dan Levitt
16 papers receiving 455 citations
Peers
Comparison fields: 5 of 59
- Immunology 177
- Physiology 113
- Immunology and Allergy 25
- Microbiology 25
- Oncology 96
Countries citing papers authored by Dan Levitt
This map shows the geographic impact of Dan Levitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Levitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Levitt more than expected).
Fields of papers citing papers by Dan Levitt
This network shows the impact of papers produced by Dan Levitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Levitt. The network helps show where Dan Levitt may publish in the future.
Co-authors
The 25 scholars most cited alongside Dan Levitt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 126 | |
| 2 | 2005 | 115 | |
| 3 | 1990 | 59 | |
| 4 | 2005 | 40 | |
| 5 | 1999 | 36 | |
| 6 | 1993 | 24 | |
| 7 | 1991 | 24 | |
| 8 | Anti-VEGF Antibody HuMV833: an EORTC Biological Treatment Development Group Phase I Toxicity, Pharmacokinetic and Pharmacodynamic Study. | 2001 | 17 |
| 9 | 1986 | 13 | |
| 10 | 2006 | 12 | |
| 11 | 2006 | 5 | |
| 12 | 1987 | 4 | |
| 13 | Interferon-alpha and interleukin-2 in the treatment of renal cell cancer. | 1990 | 3 |
| 14 | 2005 | 3 | |
| 15 | A single-gene difference associated with theophylline toxicity in mice | 1979 | 1 |
| 16 | 1980 | 1 | |
| 17 | 2001 | 1 |
About Dan Levitt
Dan Levitt is a scholar working on Immunology, Molecular Biology, Oncology, Immunology and Allergy and Epidemiology, having authored 17 papers that have together received 484 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (3 papers), Allergic Rhinitis and Sensitization (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Reproductive System and Pregnancy (2 papers), Reproductive tract infections research (2 papers), Immune Cell Function and Interaction (2 papers), Pharmacogenetics and Drug Metabolism (1 paper) and Eicosanoids and Hypertension Pharmacology (1 paper). The work is most often cited by research in Immunology (177 citations), Physiology (113 citations), Immunology and Allergy (25 citations), Microbiology (25 citations) and Oncology (96 citations). Dan Levitt has collaborated with scholars based in United States, Netherlands and Switzerland. Frequent co-authors include Feng Wu, C. K. Osborne, Naomy Kim, Gary M. Clark, Shelly McNeil, Scott A. Halperin, Joseph Eiden, Daniel Gennevois, Joanne M. Langley and J. Zeffren. Their work appears in journals such as Journal of Allergy and Clinical Immunology, Journal of Immunotherapy, The Journal of Immunology, European Journal of Cancer and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.